OKYO Pharma Limited Ordinary Shares (OKYO)
OKYO Pharma Limited is a biotechnology company focused on developing innovative therapies for eye diseases, particularly targeting ocular inflammation and neurodegeneration. The company leverages proprietary research to create treatments aimed at improving eye health and addressing unmet medical needs in ophthalmology.
Company News
OKYO Pharma plans to accelerate the clinical development of urcosimod, its drug candidate for treating neuropathic corneal pain, by analyzing data from an early closure of its Phase 2 trial. The company aims to meet with the FDA to discuss further development of urcosimod.
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) and Landos Biopharma, reported a definitive agreement under which AbbVie will acquire Landos. Landos Biopharma shares jumped 171.2% to $21.70 on Monday. Here are some other stocks moving in today's mid-day s...
Penny stocks to watch with big news. The post Trading Penny Stocks This Week? 4 To Watch With Big News appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.